Articles with "100 consecutive" as a keyword



Photo by schluditsch from unsplash

Real-World Experience With 100 Consecutive Patients Undergoing Neck Contouring With ATX-101 (Deoxycholic Acid): An Updated Report With A 2-Year Analysis

Sign Up to like & get
recommendations!
Published in 2019 at "Dermatologic Surgery"

DOI: 10.1097/dss.0000000000001811

Abstract: BACKGROUND Deoxycholic acid (DCA; ATX-101) injection was approved for the treatment of mild-to-moderate convexity associated with submental fat in 2015. OBJECTIVE To evaluate the experience with DCA injections in a clinical practice setting. MATERIALS AND… read more here.

Keywords: consecutive patients; 100 consecutive; treatment; experience ... See more keywords
Photo by irishinechka from unsplash

Implementing a Ureteric Magnetic Stent in the Kidney Transplant Setting: Report of 100 Consecutive Cases.

Sign Up to like & get
recommendations!
Published in 2019 at "Transplantation"

DOI: 10.1097/tp.0000000000002855

Abstract: BACKGROUND Kidney transplantation (KT) is the treatment of choice for end-stage kidney disease. The double-J-stent (DJS) has been used to prevent urological complications (UC) but it requires cystoscopy extraction. The novel magnetic black star (MBS)… read more here.

Keywords: 100 consecutive; report; implementing ureteric; kidney ... See more keywords
Photo from wikipedia

A single-center experience of 30-day perioperative and one year clinical outcomes of transcarotid artery revascularization in 100 consecutive patients.

Sign Up to like & get
recommendations!
Published in 2022 at "Vascular"

DOI: 10.1177/17085381221106330

Abstract: BACKGROUND Transcarotid Artery Revascularization (TCAR) using the ENROUTE system (Silk Road) has been proposed as a safe and effective alternative to both carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF-CAS). Two large registries (ROADSTER… read more here.

Keywords: stroke death; year; 100 consecutive; day perioperative ... See more keywords

Clinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.6_suppl.206

Abstract: 206Background: To report our clinical experience with 177Lutetium-labeled prostate-specific membrane antigen-ligand (177Lu-PSMA-I&T) for systemic radioligand therapy in 100 consecutive patients with metastatic castration-resistant prostate cancer (mCRPC). Methods: All patients were treated under a review board-approved… read more here.

Keywords: prostate; 100 consecutive; psma; clinical experience ... See more keywords